Frontiers in Cardiovascular Medicine · Nov 16, 2026

Trends in Population Mortality Involving Dilated Cardiomyopathy and Heart Failure in the United States From 1999 to 2024: A CDC WONDER Database Study

By Xiongda Yao, Ren-Qiang Yang, Yue Zhou et al.

Background: Long-term population mortality patterns involving co-recorded dilated cardiomyopathy (DCM) and heart failure (HF) remain insufficiently characterized. We examined temporal trends and disparities in DCM-and HF-related mortality in the United States from 1999 to 2024. Methods: Mortality data for US residents aged ≥25 years were obtained from the CDC WONDER Multiple Cause of Death datasets. Deaths involving DCM (ICD-10: I42.0) and HF-related conditions (I11.0, I13.0, I13.2, or I50) were identified. Age-adjusted mortality rates (AAMRs) were assessed by sex, race and ethnicity, and geographic characteristics; age-specific mortality rates were used for age-stratified analyses. Joinpoint regression estimated annual percentage changes (APCs) and average annual percentage changes (AAPCs). Results: During 1999–2024, 50,300 deaths were identified. National AAMR declined overall during 1999–2024, with an AAPC of −2.72% (95% CI, −3.19 to −2.22). The estimated increase during 2014 – 2022 was not statistically significant; the long-term decline persisted when DCM was required as the underlying cause. The steepest decline occurred during 2005–2014 (APC, −7.40%). AAMRs were higher among men and non-Hispanic Black individuals. Age-specific rates were highest at older ages. The three older groups had negative full-period AAPCs, but later APCs were positive: 2.10% for ages 65–74 during 2013–2024, and 2.85% and 4.01% for ages 75–84 and ≥85, respectively, during 2015–2024. Conclusions: The national long-term decline coexisted with later increases within older age groups, warranting continued attention to mortality in aging populations. Continued population surveillance, particularly in older age groups, is warranted.

The paperJournal sitePopulations

AgingResearch.News